Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35, N-His

Description of Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35, N-His

Introduction

Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 is a genetically engineered protein that has gained significant attention in the field of veterinary medicine. It is a fusion protein that combines three important components of the African swine fever virus (ASFV) – pp62, Ba71V-94, and p35. This recombinant protein has shown promising results in terms of its structure, activity, and potential applications.

Structure of Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35

The recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 is a fusion protein consisting of three distinct domains – pp62, Ba71V-94, and p35. The pp62 domain is a major structural protein of ASFV, responsible for the formation of the viral capsid. The Ba71V-94 domain is a highly immunogenic protein that has been shown to induce strong immune responses in pigs. The p35 domain is an important virulence factor of ASFV, responsible for the suppression of the host immune response.

The three domains are connected by flexible linker sequences, allowing for proper folding and stability of the recombinant protein. The resulting structure of the recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 is a large, complex protein with multiple functional domains.

Activity of Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35

The recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 has been shown to have multiple activities, making it a promising candidate for various applications. Firstly, the pp62 domain of the recombinant protein has been shown to have strong antigenic properties, making it a potential vaccine candidate against ASFV. The Ba71V-94 domain has been shown to induce strong immune responses in pigs, making it an important component for vaccine development. The p35 domain, on the other hand, has been shown to have immunosuppressive properties, which could be beneficial in controlling the severity of ASFV infection.

In addition, the recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 has been shown to have high stability and solubility, making it a suitable candidate for large-scale production. It has also been shown to have good immunogenicity and safety profiles, making it a promising candidate for use in diagnostic assays.

Applications of Recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35

The recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 has potential applications in both vaccine development and diagnostic assays. As a vaccine candidate, the recombinant protein has shown promising results in inducing protective immune responses against ASFV. It has also been shown to be safe and immunogenic, making it a potential candidate for use in live attenuated vaccines.

In terms of diagnostic assays, the recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 has been used in ELISA and western blot assays for the detection of ASFV-specific antibodies in pigs. Its high stability and solubility make it a suitable candidate for use in these assays.

Furthermore, the recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 has potential applications in the development of therapeutic agents against ASFV. The p35 domain, with its immunosuppressive properties, could be utilized to control the severity of ASFV infection and improve the survival rate of infected pigs.

Conclusion

In conclusion, the recombinant ASFV Polyprotein pp62/Ba71V-94/ASFV-p35 is a genetically engineered protein with a complex structure and multiple activities. It has shown promising results in terms of its potential applications in vaccine development, diagnostic assays, and therapeutic agents against